Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hong Zhu

Showing results (101-110 of 3,975) with videos related to

Pageof 398
Sort By:
Medicine|October 19, 2021
Partial response of donafenib as the third-line therapy in metastatic colon cancer: A case reportYang Yang, Hong Zhu, Qiu Li
The Journal of Chemical Physics|May 2, 2023
Correlated factors for Li-ion migration in ionic conductors with the fcc anion sublatticeRunxin Ouyang, Zhenming Xu, Hong Zhu
Environmental Science and Pollution Research International|May 18, 2023
Effects of cadmium, lead, mercury, chromium, and selenium co-treatment on egg quality and fatty acidsKehong Liang, Shiping Bai, Hong Zhu
Zhonghua Yi Xue Za Zhi|November 20, 2012
[Experimental studies of effects of hydrogen-rich saline in rats with severe acute pancreatitis]De-qing Zhang, Jian-hong Zhu
Experimental and Therapeutic Medicine|August 18, 2022
Blood CDC42 overexpression is associated with an increased risk of acute exacerbation, inflammation and disease severity in patients with chronic obstructive pulmonary diseaseXiaoyan Ming, Fan Yang, Hong Zhu
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|June 20, 2024
Immune checkpoint inhibitor combinations for patients with advanced endometrial cancer: a network meta-analysis and cost-utility analysisYouwen Zhu, Kun Liu, Hong Zhu
International Journal of Molecular Sciences|October 28, 2023
Predictive Biomarkers for Immunotherapy in Gastric Cancer: Current Status and Emerging ProspectsWanting Hou, Yaqin Zhao, Hong Zhu
Molecules (Basel, Switzerland)|November 14, 2023
Structure-Activity Relationship Target Prediction Studies of Clindamycin Derivatives with Broad-Spectrum Bacteriostatic Antibacterial PropertiesYiduo Jia, Yinmeng Zhang, Hong Zhu
Pharmaceuticals (Basel, Switzerland)|March 28, 2024
Clindamycin Derivatives: Unveiling New Prospects as Potential Antitumor AgentsYiduo Jia, Yinmeng Zhang, Hong Zhu
Liver International : Official Journal of the International Association for the Study of the Liver|August 18, 2023
Immune checkpoint inhibitor for patients with advanced biliary tract cancer: A cost-effectiveness analysisYouwen Zhu, Kun Liu, Hong Zhu
Pageof 398

Showing results (101-110 of 3,975) with videos related to

Sort By:
Pageof 398
Medicine|October 19, 2021
Partial response of donafenib as the third-line therapy in metastatic colon cancer: A case reportYang Yang, Hong Zhu, Qiu Li
The Journal of Chemical Physics|May 2, 2023
Correlated factors for Li-ion migration in ionic conductors with the fcc anion sublatticeRunxin Ouyang, Zhenming Xu, Hong Zhu
Environmental Science and Pollution Research International|May 18, 2023
Effects of cadmium, lead, mercury, chromium, and selenium co-treatment on egg quality and fatty acidsKehong Liang, Shiping Bai, Hong Zhu
Zhonghua Yi Xue Za Zhi|November 20, 2012
[Experimental studies of effects of hydrogen-rich saline in rats with severe acute pancreatitis]De-qing Zhang, Jian-hong Zhu
Experimental and Therapeutic Medicine|August 18, 2022
Blood CDC42 overexpression is associated with an increased risk of acute exacerbation, inflammation and disease severity in patients with chronic obstructive pulmonary diseaseXiaoyan Ming, Fan Yang, Hong Zhu
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|June 20, 2024
Immune checkpoint inhibitor combinations for patients with advanced endometrial cancer: a network meta-analysis and cost-utility analysisYouwen Zhu, Kun Liu, Hong Zhu
International Journal of Molecular Sciences|October 28, 2023
Predictive Biomarkers for Immunotherapy in Gastric Cancer: Current Status and Emerging ProspectsWanting Hou, Yaqin Zhao, Hong Zhu
Molecules (Basel, Switzerland)|November 14, 2023
Structure-Activity Relationship Target Prediction Studies of Clindamycin Derivatives with Broad-Spectrum Bacteriostatic Antibacterial PropertiesYiduo Jia, Yinmeng Zhang, Hong Zhu
Pharmaceuticals (Basel, Switzerland)|March 28, 2024
Clindamycin Derivatives: Unveiling New Prospects as Potential Antitumor AgentsYiduo Jia, Yinmeng Zhang, Hong Zhu
Liver International : Official Journal of the International Association for the Study of the Liver|August 18, 2023
Immune checkpoint inhibitor for patients with advanced biliary tract cancer: A cost-effectiveness analysisYouwen Zhu, Kun Liu, Hong Zhu
Pageof 398